Is Regeneron Pharmaceuticals, Inc. (REGN) A Good Stock To Buy?

Is REGN a good stock to buy? We came across a bullish thesis on Regeneron Pharmaceuticals, Inc. on Ocular Capital’s Substack. In this article, we will summarize the bulls’ thesis on REGN. Regeneron Pharmaceuticals, Inc.’s share was trading at $774.66 as of March 11th. REGN’s trailing and forward P/E were 18.68 and 18.05, respectively according to Yahoo Finance.

Nestor Rizhniak/Shutterstock.com

Regeneron Pharmaceuticals, Inc. (REGN) stands out as a powerful innovation engine within...